Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.27 EUR | -0.68% |
|
+2.07% | +1.14% |
09/07 | Valmet Books Order for Tissue Production Line from Velvet Care | MT |
09/07 | Valmet to Supply the Third Advantage DCT 200 Tissue Production Line to Velvet Care Paper Mill in Poland | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Ratings chart - Surperformance
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.14% | 536.73Cr | - | ||
-7.34% | 1.39TCr | B | ||
+119.49% | 560.55Cr | A- | ||
+12.06% | 444.62Cr | B | ||
-14.09% | 438.16Cr | C | ||
+12.52% | 436.64Cr | B- | ||
+20.65% | 400.76Cr | B- | ||
+16.32% | 388.14Cr | B- | ||
+7.52% | 356.27Cr | B+ | ||
-35.31% | 353.2Cr | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- VALMT Stock
- 2VO Stock
- Ratings Valmet Oyj